0001564590-21-055805 | 10-Q | XBRL Viewer

Label	Element	Value
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	$ 1,112,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1,112,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1,808,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1,808,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1,973,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1,973,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	385,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	385,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	631,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	631,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	700,000
Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition	tmdx_AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	700,000
Reversal Of Estimated Offering Costs	tmdx_ReversalOfEstimatedOfferingCosts	43,000
Reversal Of Estimated Offering Costs	tmdx_ReversalOfEstimatedOfferingCosts	43,000
Non Cash Interest And End Of Term Accretion Expense	tmdx_NonCashInterestAndEndOfTermAccretionExpense	401,000
Non Cash Interest And End Of Term Accretion Expense	tmdx_NonCashInterestAndEndOfTermAccretionExpense	379,000
Customer Payments Recorded As Operating Expenses	tmdx_CustomerPaymentsRecordedAsOperatingExpenses	400,000
Customer Payments Recorded As Operating Expenses	tmdx_CustomerPaymentsRecordedAsOperatingExpenses	1,600,000
Customer Payments Recorded As Operating Expenses	tmdx_CustomerPaymentsRecordedAsOperatingExpenses	300,000
Customer Payments Recorded As Operating Expenses	tmdx_CustomerPaymentsRecordedAsOperatingExpenses	1,100,000
Minimum Liquidity Covenant Amount	tmdx_MinimumLiquidityCovenantAmount	3,000,000.0
Long Term Debt Noncurrent Before Debt Discount And Accrued Payments	tmdx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments	35,000,000
Long Term Debt Noncurrent Before Debt Discount And Accrued Payments	tmdx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments	35,000,000
Tenant Improvements Allowance Receivable	tmdx_TenantImprovementsAllowanceReceivable	$ 100,000
Class Of Warrant Or Rights Expiration Date	tmdx_ClassOfWarrantOrRightsExpirationDate	Nov. 07, 2022
Class Of Warrant Or Rights Expiration Date	tmdx_ClassOfWarrantOrRightsExpirationDate	May 06, 2024
Stock Issuance Costs And Discounts	tmdx_StockIssuanceCostsAndDiscounts	$ 628,000
Clinical Trial Expense	tmdx_ClinicalTrialExpense	100,000
Clinical Trial Expense	tmdx_ClinicalTrialExpense	43,000
Clinical Trial Expense	tmdx_ClinicalTrialExpense	882,000
Clinical Trial Expense	tmdx_ClinicalTrialExpense	1,123,000
Clinical Trial Expense	tmdx_ClinicalTrialExpense	2,127,000
Proceeds From Paycheck Protection Program Loan	tmdx_ProceedsFromPaycheckProtectionProgramLoan	2,249,000
Inventory Transfer To Property Plant And Equipment	tmdx_InventoryTransferToPropertyPlantAndEquipment	935,000
Inventory Transfer To Property Plant And Equipment	tmdx_InventoryTransferToPropertyPlantAndEquipment	705,000
Guaranteed Minimum Annual Royalty Payment	tmdx_GuaranteedMinimumAnnualRoyaltyPayment	$ 100,000
Recorded Unconditional Purchase Commitment Maturity Year And Month	tmdx_RecordedUnconditionalPurchaseCommitmentMaturityYearAndMonth	2029-12
Leasehold Improvements Landlord Allowance	tmdx_LeaseholdImprovementsLandlordAllowance	$ 3,400,000
Repayment Of Paycheck Protection Program Loan	tmdx_RepaymentOfPaycheckProtectionProgramLoan	$ 2,249,000
Debt Instrument Maturity Month And Year	tmdx_DebtInstrumentMaturityMonthAndYear	2023-06
Proceeds From Issuance Of Common Stock In Initial Public Offering Net Of Underwriting Discounts And Commissions	tmdx_ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions	$ 75,670,000
Common Stock Held By Non Affiliates	tmdx_CommonStockHeldByNonAffiliates	$ 700,000,000.0

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accrued Expenses And Other Current Liabilities [Abstract]
Accrued research, development and clinical trials expenses	$ 4,505	$ 4,426

Print Document View Excel Document
Notes Details Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail) Uncategorized Uncategorized Items - tmdx-10q_20210930_htm.xml All Reports